Cited in:


This article has been cited by:

  1. 1
    Flavia F. Fernandes, Maria L. Ferraz, Luiz E. Andrade, Alessandra Dellavance, Carlos Terra, Gustavo Pereira, João L. Pereira, Frederico Campos, Fátima Figueiredo, Renata M. Perez, Enhanced Liver Fibrosis Panel as a Predictor of Liver Fibrosis in Chronic Hepatitis C Patients, Journal of Clinical Gastroenterology, 2015, 49, 3, 235


  2. 2
    Joanne R. Morling, Jonathan A. Fallowfield, Rachel M. Williamson, Lisa D. Nee, Andrew P. Jackson, Stephen Glancy, Rebecca M. Reynolds, Peter C. Hayes, Indra N. Guha, Mark W. J. Strachan, Jackie F. Price, Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes study, Liver International, 2014, 34, 8
  3. 3
    Beom Kyung Kim, Hyon-Suk Kim, Eun Jin Yoo, Eun Ji Oh, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim, Young Nyun Park, Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test, Hepatology, 2014, 60, 6